Davidson Kempner Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-43,400
Closed -$5.7M 180
2019
Q4
$5.7M Buy
+43,400
New +$5.03M 0.13% 110

Other funds holding LLY

Davidson Kempner Capital Management's LLY Position: Q1 2020 in Review

Davidson Kempner Capital Management sold out of Eli Lilly (LLY) in Q1 2020, closing a stake of 43,400 shares — an estimated $5.7M sold.

Davidson Kempner Capital Management first reported a position in LLY in Q4 2019 and held it in 1 quarter. The position peaked at $5.7M in Q4 2019. 1,684 funds tracked by Wall St. Rank hold LLY as of Q1 2020.

  • Davidson Kempner Capital Management reported no remaining Eli Lilly position as of Q1 2020 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 43,400 Eli Lilly shares in Q1 2020, an estimated $5.7M.
  • Davidson Kempner Capital Management first reported a position in Eli Lilly in Q4 2019 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Eli Lilly position peaked at $5.7M in Q4 2019.
  • 1,684 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2020.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2020, filed 15 May 2020.